1204176-39-5

Basic information

• Product Name: 2-Fluoro-3-isopropoxybenzaldehyde
• Synonyms: 2-Fluoro-3-isopropoxybenzaldehyde
• CAS NO: 1204176-39-5
• Molecular Formula: C₁₀H₁₁FO₂
• Molecular Weight: 182.1915432
• Mol File: 1204176-39-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Fluoro-3-isopropoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Fluoro-3-isopropoxybenzaldehyde(1204176-39-5)
• EPA Substance Registry System: 2-Fluoro-3-isopropoxybenzaldehyde(1204176-39-5)

Safety Data

• Hazardous Substances Data: 1204176-39-5(Hazardous Substances Data)

Upstream product

• 367-12-4 2-fluorophenol 
• 1160293-58-2 1-fluoro-2-isopropoxybenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 1204182-30-8 2-fluoro-3-isopropoxybenzonitrile 
• 1000339-24-1 2-fluoro-3-hydroxybenzonitrile 

Downstream Products

• 1204176-37-3 (R)-tert-butyl 1-(2-formyl-6-isopropoxyphenyl)piperidin-3-ylcarbamate 

Relevant articles and documents

GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel geminal substituted quinuclidine amide compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7- nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

CHEMICAL COMPOUNDS 251

The invention relates to chemical compounds of formula (I), and salts thereof. In some embodiments, the invention relates to inhibitors or modulators of PIM-1 and/or PIM-2, and/or PIM-3 protein kinase activity or enzyme function. In still further embodiments, the invention relates to pharmaceutical compositions comprising compounds disclosed herein, and their use in the prevention and treatment of PIM kinase related conditions and diseases, preferably cancer.